Therefore, within this heterogeneous landscape, we performed a comprehensive review of our institutional data for some of the most common neurosurgical diseases amenable to SRS treatment, including AVM, meningioma, vestibular schwannoma, glomus jugulare tumor, brain metastases, spine metastases, GBM, and trigeminal neuralgia (TN). Although the effectiveness of and the indications for CK and other SRS techniques are already well established for some neurosurgical disorders, such as brain metastases, they are still debated for other diseases, such as arteriovenous malformation (AVM), and are under investigation for still other conditions, such as glioblastoma (GBM). At our institution, CK has been extensively used to treat numerous cancerous and noncancerous disorders of the nervous system.
Since then, CK has been used worldwide to treat a myriad of clinical conditions.
T he CyberKnife (CK Accuray Inc.) is a noninvasive frameless image-guided stereotactic radiosurgery (SRS) platform developed in 1994 by Stanford University–based neurosurgeon Dr.
0 kommentar(er)
